Peter Winstanley

Mefloquine: the benefits outweigh the risks.

P. Winstanley, Peter Winstanley, 1996, British journal of clinical pharmacology.

Molecular evidence of greater selective pressure for drug resistance exerted by the long-acting antifolate Pyrimethamine/Sulfadoxine compared with the shorter-acting chlorproguanil/dapsone on Kenyan Plasmodium falciparum.

E. Nduati, A. Nzila, S. Monks, 2000, The Journal of infectious diseases.

The effects of food on drug bioavailability.

P. Winstanley, M. Orme, Peter Winstanley, 1989, British journal of clinical pharmacology.

Population Pharmacokinetics of Sulfadoxine and Pyrimethamine in Malawian Children With Malaria

M. Mukaka, P. Winstanley, M. Molyneux, 2011, Clinical pharmacology and therapeutics.

Modern chemotherapeutic options for malaria.

P. Winstanley, Peter Winstanley, 2001, The Lancet. Infectious diseases.

Fatal quinine cardiotoxicity in the treatment of falciparum malaria.

R. Davidson, P. Winstanley, G. Pasvol, 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.